Q2 2025 13F Holders as of 6/30/2025
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
1.74B
-
Number of holders
-
3146
-
Total 13F shares, excl. options
-
1.37B
-
Shares change
-
+26.4M
-
Total reported value, excl. options
-
$186B
-
Value change
-
+$3.61B
-
Put/Call ratio
-
0.83
-
Number of buys
-
1446
-
Number of sells
-
-1331
-
Price
-
$136.01
Significant Holders of ABBOTT LABORATORIES - Common Stock (ABT) as of Q2 2025
3,352 filings reported holding ABT - ABBOTT LABORATORIES - Common Stock as of Q2 2025.
ABBOTT LABORATORIES - Common Stock (ABT) has 3,146 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 1.37B shares
of 1.74B outstanding shares and own 78.79% of the company stock.
Largest 10 shareholders include VANGUARD GROUP INC (173M shares), BlackRock, Inc. (141M shares), STATE STREET CORP (78.4M shares), Capital International Investors (60.1M shares), Capital Research Global Investors (41.8M shares), JPMORGAN CHASE & CO (39.3M shares), GEODE CAPITAL MANAGEMENT, LLC (38.3M shares), MORGAN STANLEY (35.2M shares), WELLINGTON MANAGEMENT GROUP LLP (25.1M shares), and NORGES BANK (22.2M shares).
This table shows the top 3146 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.